Genetic cholesterol eliminated by new drug, reducing heart attack risk, study finds

Genetic cholesterol eliminated by new drug, reducing heart attack risk, study finds

Elevated Lp(a) has been an untreatable cardiovascular risk factor until now, researchers say

Researchers have discovered an experimental medication that significantly reduces a cholesterol-like particle that can increase the risk of heart attacks and strokes. (iStock)

Lipoprotein(a) levels are elevated in approximately 20-25% of people worldwide, according to the American Heart Association. (iStock)

Diet, exercise and weight loss can help decrease LDL levels, but they do not have an impact on Lp(a) levels, experts say. (iStock)

Unlike traditional cholesterol, which doctors typically monitor over time, lipoprotein(a) only needs to be checked once in a lifetime. (iStock)

The European Society of Cardiology and the National Lipid Association in the U.S. both recommend that all adults check their Lp(a) levels. (iStock)